On March 3, 2017, the United States Court of Appeals for the Federal Circuit reaffirmed, in a precedential opinion, that prosecution disclaimers may only limit the scope of a claim where the disclaimer is “both clear and...more
When the Patent Trial and Appeal Board issues a final written decision finding against an IPR Petitioner, can that Petitioner necessarily appeal that adverse decision? In a case of first impression, the Federal Circuit...more
Plaintiffs bringing patent infringement complaints under the Iqbal/Twombly pleading standard should take notice. On September 30, 2016, a panel of the Federal Circuit affirmed a district court’s dismissal of a deficient...more
10/13/2016
/ CAFC ,
CBS ,
Federal Rule 12(b)(6) ,
Joint Infringement ,
Limelight v Akamai ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pleading Standards ,
Television Broadcast Stations ,
Twombly/Iqbal Pleading Standard
On March 12, the United States District Court for the Southern District of Indiana joined the District of Delaware and Eastern District of Texas as the first courts to consider a generic drug manufacturer’s motion to dismiss...more
3/18/2015
/ Abbreviated New Drug Application (ANDA) ,
DaimlerChrysler v Bauman ,
Forum ,
Generic Drugs ,
Hatch-Waxman ,
Minimum Contacts ,
Motion to Dismiss ,
Patent Infringement ,
Patents ,
Personal Jurisdiction ,
Pharmaceutical Industry ,
Popular